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Objective: to map the scientific knowledge about COVID-19 in older adults. Method: this 
is a scoping review literature review. A search was performed in the PubMed, CINAHL, Web 
of Science and LILACS databases. Original articles that answered the guiding question were 
included: what scientific knowledge is available in the world about COVID-19 in older adults? 
Results: thirty-one articles were included, most of them carried out in China (n=23) and with 
a retrospective design (n=13) and case studies/case series (n=13). Based on the findings, six 
thematic categories emerged: clinical signs and symptoms (n=12), other information (n=9), 
adverse outcomes/complications resulting from COVID-19 (n=8), age relationship and greater 
severity of COVID-19 (n=8), variables related to death by COVID-19 (n=8), and diagnostic 
findings (n=8). Conclusion: the findings reinforce older adults’ greater vulnerability to the 
worsening of COVID-19, as well as to complications resulting from the disease, including 
the greater occurrence of death.
Descriptors: Aged; Coronavirus; Severe Acute Respiratory Syndrome; Coronavirus Infections; 
Geriatric Nursing.
RESUMO
Objetivo: mapear o conhecimento científico sobre a COVID-19 no idoso. Método: revisão 
da literatura do tipo scoping review. Realizou-se uma busca nas bases de dados PubMed, 
CINAHL, Web of Science e LILACS. Incluíram-se os artigos originais que responderam à questão 
norteadora: quais os conhecimentos científicos disponíveis no mundo sobre a COVID-19 
no idoso? Resultados: foram incluídos 31 artigos, a maioria realizada na China (n=23) e 
de delineamento retrospectivo (n=13) e estudos de casos/série de casos (n=13). Com base 
nos achados, emergiram seis categorias temáticas: sinais e sintomas clínicos (n=12); outras 
informações (n=9); desfechos adversos/complicações decorrentes da COVID-19 (n=8); relação 
da idade e maior gravidade da COVID-19 (n=8); variáveis relacionadas ao óbito pela COVID-19 
(n=8); achados diagnósticos (n=8). Conclusão: os achados reforçam a maior vulnerabilidade 
do idoso ao agravamento da COVID-19, bem como as complicações decorrentes da doença, 
incluindo a maior ocorrência de óbito.
Descritores: Idoso; Coronavírus; Síndrome Respiratória Aguda Grave; Infecções por Coronavírus; 
Enfermagem Geriátrica. 
RESUMEN
Objetivo: mapear el conocimiento científico sobre COVID-19 en ancianos. Método: revisión 
de la literatura del tipo scoping review. Se realizó una búsqueda en las bases de datos PubMed, 
CINAHL, Web of Science y LILACS. Se incluyeron artículos originales que respondieron a la 
pregunta orientadora: ¿qué conocimiento científico está disponible en el mundo sobre el 
COVID-19 en los ancianos? Resultados: se incluyeron 31 artículos, la mayoría realizados 
en China (n=23) y con un diseño retrospectivo (n=13) y estudios de casos/series de casos 
(n=13). A partir de los hallazgos, surgieron seis categorías temáticas: signos y síntomas 
clínicos (n=12); otra información (n=9); resultados/complicaciones adversos resultantes de 
COVID-19 (n=8); relación de edad y mayor gravedad de COVID-19 (n=8); variables relacionadas 
con la muerte por COVID-19 (n=8); hallazgos diagnósticos (n=8). Conclusión: los hallazgos 
refuerzan la mayor vulnerabilidad de los ancianos al agravamiento del COVID-19, así como 
las complicaciones derivadas de la enfermedad, incluida la mayor ocurrencia de muerte.
Descriptores: Anciano; Coronavirus; Síndrome Respiratorio Agudo Grave; Infecciones por 
Coronavírus; Enfermería Geriátrica.
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INTRODUCTION
COVID-19 is an acute respiratory disease caused by the new 
coronavirus (SARS-CoV-2)(1), which was declared a Public Health 
Emergency of International Concern and characterized as a 
pandemic on March 11, 2020(2). The clinical picture of COVID-19, 
in most cases, has been reported as similar to other respiratory 
infections, with fever (≥37.8ºC), coryza, cough, usually dry and 
tired(3). The reverse-transcriptase polymerase chain reaction (RT-
PCR, polymerase chain reaction with reverse transcription) by 
nasopharyngeal swab was the reference standard for definitive 
diagnosis of infection with the new coronavirus(3). However, it 
is estimated that 5% of those infected develop the most severe 
form of the disease, with symptoms of dyspnea and/or signs of 
pulmonary bleeding, severe lymphopenia, and kidney failure(3). 
Due to the physiological changes that occur with the human 
aging process and compromise the immune system, and the 
greater number of complications resulting from chronic diseases, 
older adults have been the most vulnerable to severe forms of 
COVID-19 and for evolution to death(4). In an epidemiological 
cohort study conducted in China, most cases of COVID-19 and 
the worst prognosis for this disease were among older adults(5). 
Supporting these findings, data demonstrated that the occur-
rence of death by COVID-19 increased exponentially from 3 to 5% 
among people aged 65├75 years, from 4 to 11% among people 
aged 75├85 years and from 10 to 27% among people aged 85 
years and over. Moreover, people aged 65 and over represented 
45% more hospital admissions, 53% of occupations in Intensive 
Care Units and 80% of deaths(6). This leads to the belief that more 
comprehensive measures are needed to protect older adults.
In this regard, studies are needed to subsidize the care of health 
professionals to older adults with COVID-19 and, likewise, to give 
direction to sectoral and intersectoral actions under an integrat-
ing look among all instances involved in facing this pandemic 
situation. This scientific basis can support health teams’ work, 
in order to develop interventions that can favor older adults’ 
management and health care. 
Given the above, the scoping review is considered a useful 
tool to identify and synthesize scientific knowledge(7), especially 
in the COVID-19 pandemic, enabling planning care actions for 
older adults, which are foundations in evidence-based practice. 
Furthermore, assessment of studies may target priority areas that 
need to advance knowledge on this emerging topic. 
OBJECTIVE
To map the scientific knowledge about COVID-19 in older adults.
METHODS
This is scoping review literature developed according to the 
Joanna Briggs Institute protocol(7).
To develop the research question, Population, Concept and 
Context (PCC)(7) was used, being: P - older adults; C - COVID-19; 
C - scientific knowledge. Thus, the guiding question was estab-
lished: what scientific knowledge is available in the world about 
COVID-19 in older adults? Older adults were defined as persons 
aged 60 and over(8); COVID-19 was considered to be the disease 
caused by the new coronavirus (2019 novel coronavirus, acronym 
2019-nCoV)(1). 
As an eligibility criterion, original articles, case reports and 
case series were all considered, all about COVID-19 and with 
data referring to older adults, from December 2019, when the 
first study on said disease(1). Letters to the editor, opinion articles, 
and reflection articles were excluded.
Search strategy
In the first stage, a search was carried out in the National 
Library of Medicine National Institutes of Health (PubMed), Cu-
mulative Index to Nursing and Allied Health Literature (CINAHL) 
databases, in which titles, abstracts and descriptors found were 
analyzed. In the second stage, all keywords and descriptors were 
used to identify the articles in other databases: Web of Science 
and Latin American and Caribbean Literature in Health Sciences 
(LILACS). In the third stage, the studies published on the PubCo-
vid-19 platform (http://pubcovid19.pt/index.php), which covers 
articles published on COVID-19, divided into several themes, 
were analyzed as an additional source. Studies on the theme 
“older adults” were considered.
Search for primary studies was carried out on April 17, 2020. 
To that end, controlled and uncontrolled descriptors were de-
limited according to the databases using advanced search tools, 
i.e., the selected descriptors were crossed and combined using 
the Boolean operators “AND” and “OR”. The controlled descrip-
tors (MESH) adopted in search strategy for primary studies were 
“Coronavirus, Coronavirus Infections”, “Severe Acute Respiratory 
Syndrome”, “SARS Virus” and “aged”, “aged, 80 and over”.
Considering that there are no specific descriptors available 
for the new coronavirus and that the first case of the disease 
was reported in December 2019(1), the time frame was used to 
search the databases for primary studies (December 2019 until 
the data collection time).
Study selection and data extraction
The articles found were imported into the program on the 
Web Endnote - Clarivate Analytics (https://access.clarivate.com/
login?app=endnote) for identification and exclusion of duplicates. 
Subsequently, the Rayyan QCRI - Qatar Computing Research 
Institute (https://rayyan.qcri.org/welcome) program was used 
to manage the selection process of the final sample. 
For data extraction, a script was elaborated containing infor-
mation related to authorship, year and place of publication, type 
of study, participants, study period, and results. Article assess-
ment and data extraction were conducted by two independent 
reviewers (NGNO and MADR), with disagreements sorted out by 
a third reviewer (AFB). 
Analysis of evidence
Data synthesis was performed descriptively considering the 
construction of thematic categories, which addressed the results 
of original studies on COVID-19 in older adults worldwide.
3Rev Bras Enferm. 2021;74(Suppl 1): e20200938 12of
Scientific knowledge about infections by the new coronavirus in older adults: a scoping review
Tavares DMS, Oliveira NGN, Rezende MAD, Bitencourt GR, Silva MB, Bolina AF. 
RESULTS
The Preferred Reporting Items for Systematic Review and 
Meta-Analys for Scoping Reviews (PRISMA) diagram(9) was used 
to present the article selection steps (Figure 1).
In the first stage, 440 articles were found in the databases and 
79 identified in the PubCovid-19 Platform, 103 of which were 
excluded by duplicate. After reading all titles and abstracts, 92 
articles were included for reading in full, in order to answer the 
research question. Studies that did not meet the inclusion criteria 
(n=61) were excluded due to different population (n=19), study 
design (n=37), and others (n=5). Therefore, 31 articles made up 
the final sample of this scoping review (Figure 1).
Of the 31 articles analyzed, all were published in 2020 and 
the majority in China (n=23). Case report (n=13) and retrospec-
tive (n=13) studies figured prominently, which aimed mainly to 
investigate the epidemiological, clinical and diagnostic charac-
teristics of COVID-19.
With regard to case studies/case series (n=13), a large part (n=6) 
occurred in January 2020 aiming to report, by and large, the clinical 
characteristics, the diagnostic findings and the prospects for treat-
ment of the first confirmed cases for COVID-19. Other information 
was highlighted in these reports, such as: improvement of serial 
laboratory parameters and oxygenation with the infusion of plasma 
in treatment of two older adults hospitalized with COVID-19(10); the 
best clinical evolution of a female older adult immunocompromised 
in relation to her immunocompetent spouse(11); syncope(12), malnutri-
tion(13) and rhabdomyolysis(14) in cases of older adults with COVID-19; 
and diagnostic findings by computed tomography(15-17) (Chart 1). 
Chart 1 - Characteristics of case reports or case series on COVID-19 in older adults according to authorship, year of publication, country, type of study, 




study Study participants/period Main results
Ahn YJ et al., 
2020 (Korea)(10) Case studies
- 02 patients with COVID-19 with acute 
respiratory syndrome (71 years and 67 years).
- Period: February and March 2020.
-When receiving lopinavir/ritonavir and hydroxychloroquine, 
older adults maintained persistent fever, hypoxemia, and 
progressive bilateral infiltrations.
- After plasma infusion, patients showed improvement in 
oxygenation and chest X-ray, and a decrease in inflammatory 
markers and viral loads.
- After application of methylprednisolone, before plasma 




Ulrich I, 2020 
(Italy)(11)
Case studies
- 02 patients with COVID-19 (couple), the 
woman being treated with chemotherapy 
for recurrent breast cancer, and her husband 
considered healthy (controlled hypertension). 
Both 60 years old.
- Period: March 2020.
- Both patients were treated with darunavir/cobicistat and 
hydroxychloroquine.
- The immunocompromised woman evolved, without the need 
for intensive care and was discharged after 6 days.
- The husband needed intensive care and his recovery was slow, 
although he was also discharged from the hospital.
Chantal Tapé 
BA et al., 2020 
(United States)(12)
Case study
- 01 female older adult with COVID-19 (79 
years).
- Period: not specified.
- Older adult with previous cardiovascular disease presented with 
syncope episode; she was afebrile, with a normal chest X-ray and 
with no suspicion of COVID-19.
- In 03 days, she developed a fever and tested positive for COVID-19.
- Syncope may be a symptom of COVID-19 in older adults with 
cardiovascular diseases.
Yuan Y et al., 
2020 (China)(13) Case series
- 06 patients with COVID-19, being 04 older 
adults (02 men - 65 and 64 years old; and 02 
women - 64 and 71 years old).
-Period: January 2020
- All older adult patients had malnutrition;
- Nutritional status can be useful in identifying older adults at 
high risk with COVID-19.
To be continued
The synthesis of scientific knowledge was distributed in two 
groups according to study design, the first being case reports/
case series (n=13) (Chart 1); and the second according to other 
scientific results (n=18) about COVID-19 in older adults (Chart 2).
Studies selected by reading 
abstracts and titles
(n=92)
Articles deleted after full reading
 (n=61)
Reasons for exclusion 
- Different population (n=19)
- Study design (n=37)
- Other reasons (n=5)
Articles deleted after reading titles 
and abstracts
(n=324)






















Articles after removing duplicates
(n=416)





Web of Science (n=42)
LILACS (n=7)




Full articles assessed 
for eligibility 
(n=31)
Figure 1 - Flow diagram of study selection in the databases according to 
Preferred Reporting Items for Systematic Review and Meta-Analyzes for 
Scoping Reviews (PRISMA)(9) 
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study Study participants/period Main results
Suwanwongse 
K et al., 2020 
(United States)(14)
Case study - 01 patient with COVID-19 (88 years).- Period: not specified.
- Patient with hypertension, chronic kidney disease, heart failure 
with reduced ejection fraction, benign prostatic hypertrophy, 
bilateral knee osteoarthritis, and mild cognitive impairment.
- Entered the emergency room with symptoms of 
rhabdomyolysis, including muscle pain and weakness.
- In the initial assessment, she had low fever, tachypnea, and 94% 
oxygen saturation.
- The COVID-19 polymerase chain reaction test of the 
nasopharyngeal swab was positive.
Chen X et al., 
2020 (China)(15) Case study
- 03 patients with COVID-19, one of whom is 
an older adult (67 years old).
Period: not specified.
- Chest CT scan without contrast showed multiple, bilateral, 
irregular ground-glass opacities with a paving pattern. Using 
an antiviral (Abidore) did not help to reduce the patient’s 
temperature, nor to improve her breathing pattern.
- After four days, chest computed tomography was repeated, and 
demonstrated increased multiple consolidation, ground-glass 
nodules and ground-glass nodules adjacent to the pleura.
- The patient received intravenous administration of 
methylprednisolone (40 mg qd), oral administration of 
γ-immunoglobulin and traditional Chinese medicine and non-
invasive positive pressure ventilation. The dynamic computed 
tomography showed irregular consolidation and partially 
absorbed nodules, indicating that the symptoms were alleviated.
Moreira BL et al., 
2020 (Brazil)(16) Case study
- 01 older adult with COVID-19 (73 years).
- Period: not specified.
- On chest radiography, he presented ill-defined pulmonary 
opacities, notably on the periphery of the left lung.
- On chest computed tomography, he presented ground-glass 
opacities, predominantly peripheral, involving all pulmonary lobes.
Quin C et al., 
2020 (China)(17) Case series
- 04 patients with COVID-19, 01 older adult 
(woman and 61 years old)
- Period: January 13th to 20th, 2020
- The older adult patient had back pain and a dry cough, mild 
leukopenia, peripheral ground-glass opacities, and pulmonary 
consolidations in more than two pulmonary lobes.
Lescure FX 
et al., 2020 
(France)(18)
Case study
- 05 patients with COVID-19, one of whom is 
an older adult (80 years old).
- Period: January 2020.
- The older adult patient presented rapid evolution to multiple 
organ failure and high and persistent viral load in the lower and 
upper respiratory tract.
- The older adult patient died 24 days after the disease; and 
everyone else recovered and was discharged.




- 02 female older adults with COVID-19 (60 
years and 70 years).
- Period: January 2020.
- Genomes of the cases are identical. These genomes have no 
direct link to the Huanan Seafood Market, but their genomes are 
identical to four Wuhan strings, collected on December 30, 2019, 
indicating a potentially wider distribution in the city.
Wang Z et al., 
2020 (China)(20) Case series
- 04 patients with COVID-19, 02 older adults 
(63-year-old woman; 63-year-old man).
- Period: January 21th and 24th, 2020.
- Signs and symptoms in older adult patients: fever and cough. 
The woman also had vertigo and constipation.
- On tomography, the man presented unilateral pneumonia, and 
the older adult, bilateral.
- Both older adults received oxygen therapy, treatment with 
antibiotics and antivirals with lopinavir/ritonavir (Kaletra®), 
arbidol and Shufeng Jiedu Capsule. The woman was on 
mechanical ventilation.
- The man improved the symptoms associated with pneumonia, 
and the first test was negative.
- At the end of data collection, the woman showed signs of 
improvement in pneumonia.
Zang W, 2020 
(China)(21) Case study
- 01 male older adult (75 years old).
- Period: not specified.
- Hypertensive and diabetic older adults were diagnosed with severe 
COVID-19 pneumonia associated with Severe Acute Respiratory 
Syndrome and septic shock.
- In the physical exam he did not present fever; however, even though 
using non-invasive oxygen therapy, oxygen saturation was 91%.
- The three-dimensional reconstruction of bilateral lung injuries 
provided a fundamental clue for early identification of COVID-19.
Chan JFW et al., 
2020 (China)(22) Case study 06 people, 05 with a diagnosis of COVID-19, being 03 older adults, 02 female (65 and 66 
years old) and 01 male (66 years old).
Period: January 2020.
- Older adults showed more systemic symptoms (fever ≥38.2ºC), 
extensive ground-glass radiological changes, lymphopenia, 
thrombocytopenia and increased levels of C-reactive protein and 
lactic dehydrogenase.
Chart 1 (concluded)
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As for other designs of the studies (n=18) (Chart 2), it was found 
that two were carried out only with older adults, in the others 
(n=16), participants were constituted by the general popula-
tion, which presented results on COVID-19 stratified according 
to age group, which included older adults. The number of study 
participants ranged from 17(1) to 13,909(23) older adults, with 
heterogeneous selection criteria, being: confirmed diagnoses of 
COVID-19(6.24-31); pneumonia by COVID-19(1.31-33); adults with one 
or more morbidities(34); deaths associated with COVID-19(23.35); 
suspected cases(32) and confirmed symptomatic of the disease(36). 
The sample data, from most surveys, were related to the period 
of January and/or February (n=13). The consecutive and non-
probabilistic sample was used in 17 studies (Chart 2). 
Based on the findings of the studies included in this scoping 
review (n=31), six thematic categories of the main results of stud-
ies on COVID-19 in older adults were listed, as shown in Chart 3. 
Chart 2 - Characteristics of scientific knowledge about COVID-19 in older adults according to authorship, year of publication, country, type of study, 
study participants, period, and main results
Author, year, 
and country Type of study Study participants/Period Main results




-95 patients with pneumonia by COVID-19, 
17 of whom are older adults (> 60 years 
old).
- Period: January 16th to February 25th 
(2020).
- 41.2% of older adults were severe cases of COVID-19 and reached 
the compound endpoint (admission to an Intensive Care Unit, 
mechanical ventilation, or death).




- 32,583 patients with COVID-19, 13,818 
older adults (≥ 60 years old).
- Period: December 8th (2019) to March 8th 
(2020).
- The risk of severity of COVID-19 increased with age. Older adults 
aged 80 years or older had a higher risk of having severe COVID-19 
(41.3%; OR: 3.61 [95% CI, 3.31-3.95]).
Verity R et al., 
2020 (China)(23) Analytic study
- 194 deaths and 30,763 infected in people 
<60 years old/829 deaths and 13,909 
infected people aged ≥60 years old
- Period: cases reported in China until 
February 8th and outside China until 
February 25th (2020).
- The estimated rate, by the parametric method, of case fatality 
was lower in those under 60 years old (1.4% [0.4-3.5]) compared to 
those aged 60 and over (4, 5% [1.8-11, 1]).
- It was observed a higher proportion of more severe cases as the 
age group increases: 11.8% (7.01–24.0) between 60–69 years old; 
16.6% (9.87–33.8) between 70–79 years old and 18.4% (11.0–37.6) 
≥80 years.




- 788 patients with COVID-19, 136 older 
adults (≥ 60 years old).
- Period: January 17th to February 12th 
(2020).
-The presence of comorbidities was higher in older adults (55.1%) 
compared to younger ones (21.9%) (p <0.001).
- Higher proportion of older adults among the most severe patients 
(16.2%; p <0.001) and critically ill (8.8%; p <0.001), with shortness of 
breath (12.5%; p <0.001) and fever> 39.0℃ (14.0%; p=0.010).
- There was no statistically significant difference between the groups 
regarding the time of disease onset and first consultation (p=0.867), 
confirmation of diagnosis (p=0.410), and hospitalization (p=0.945).
- The highest proportion of admissions to Intensive Care Units (9.56%; 
p <0.001) and applications of methylprednisolone (28.68%; p <0.001) 
was among older adults.





- 1,591 patients with COVID-19, 961 older 
adults (≥ 61 years).
- Period: February 20th to March 18th (2020).
- All long-lived patients (100%) and 76% of older adults aged 60 and 
over had at least one comorbidity.
- Invasive mechanical ventilation was used in 89% of older adults.
- Non-invasive ventilation was used in 10% of older adults.
- Mortality in Intensive Care Units was higher in older adults (36%; p 
<0.001).
- Percentage of patients discharged from Intensive Care Units was 
lower among older adults (11%; p <0.001).





- 339 older adults (> 60 years) with 
COVID-19.
- Period: January 1st to February 6th (2020).
- Mean age was 71 ± 8 years; 51% were female; 23.6% were critically ill 
patients; 46.9% were critically ill patients; 29.5% were moderate cases.
- Common comorbidities: hypertension (40.8%), diabetes mellitus 
(16.0%), and cardiovascular diseases (15.7%).
The most common symptoms were fever (92.0%), cough (53.0%), 
dyspnea (40.8%), and fatigue (39.9%).
- Lymphocytopenia was a common laboratory finding (63.2%).
- Common complications: bacterial infection (42.8%), abnormalities 
of liver enzymes (28.7%), and acute respiratory distress syndrome 
(21.0%).
- 26.8% were discharged and 19.2% died.
- A shorter length of stay was found among those who died (5 days) 
compared to survivors (28 days) (p <0.001).
- Dyspnea symptoms (OR: 2.35; p=0.001), comorbidities, including 
cardiovascular disease (OR: 1.86; p=0.031) and chronic obstructive 
pulmonary disease (OR: 2.24; p=0.023) and syndrome acute respiratory 
distress (OR: 29.33; p <0.001) were strong predictors of death. A high 
level of lymphocytes was predictive of a better result (OR: 0.10; p 
<0.001
To be continued
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Author, year, 
and country Type of study Study participants/Period Main results





- 203 patients with COVID-19, 55 older 
adults (≥ 65 years).
- Period: January 1st to February 10th 
(2020).
- Among patients aged 65 and over, the mortality rate was 34.5%, 
significantly higher than that of older adults ≤ 65 years of age 
(4.7%) (p <0.001).
- Common symptoms of older adult patients with COVID-19 
included fever (94.5%), dry cough (69.1%), and dyspnea (63.6%).
-Older adults aged 65 and over had higher initial comorbidities 
(p <0.001), more severe symptoms (p <0.001) and more likely to 
multiple organ failure (p <0.001), compared to younger patients.




- 280 patients infected with SARS-CoV-2, 
being
69 older adults (≥65 years old).
- Period: January 20th to February 19th 
(2020).
- Among the older adults, a greater proportion of the severe 
condition of the disease was evidenced in relation to the mild one 
(p <0.001).
-In an multivariate analysis, the age group of 65 years and over 
was an independent risk factor for COVID-19 (OR=81.2; CI=1.10-
5988.12).





- 98 patients with COVID-19, 20 older 
adults (≥ 60 years old).
- Period: January 20th to February 17th 
(2020).
- Differences between clinical manifestations (fever and sputum) 
in infected patients of different age groups were not statistically 
significant (p> 0.05), nor was there a statistically significant 
difference in the interval between the first onset of symptoms and 
high-resolution computed tomography (p=0.921).
- A greater number of cases of bilateral pulmonary involvement 
was found in patients ≥ 60 years old in relation to the others (p 
<0.05).
- The number of lung lesions observed by high-resolution 
computed tomography in patients aged 60 years or older was 
higher compared to those younger than 18 years old (p=0.019).
- Involvement of peripheral lung injuries in the older adult 
group was greater than the group of children under 18 years old 
(p=0.005).




- 125 patients diagnosed with COVID-19, 
14 older adults (≥ 59 years old).
-Period: January 20th to February 9th (2020).
-Patients were classified as non-critical (mild, common) and critical 
(severe; critical). Critical patients were older (p=0.003) and had 
more underlying disease than non-critical patients (p=0.009).




- 425 patients with pneumonia caused by 
the new coronavirus, 240 older adults (≥ 
60 years old).
- Period: until January 22th (2020).
- Characteristics of the cases in three periods: the first period was 
for patients with disease onset before January 1st, the date on 
which the Huanan Wholesale Seafood Market was closed (older 
adults - 65 years and over - represented 23%); the second period 
was for those beginning between 1 and 11 January, which was the 
date on which the RT-PCR reagents were supplied to Wuhan (older 
adults - 65 years or older - represented 42%); and the third period 
were those with onset of the disease on or after January 12 (older 
adults - 65 years or older - represented 37%).
- It was noted that few of the first cases occurred in children, and 
almost half of the 425 cases were in adults aged 60 years and over.





- 56 patients with COVID-19 pneumonia, 
18 older adults (≥ 60 years old).
- Period: January 15th to February 18th 
(2020).
- 22.3% of older adults received mechanical ventilation in an 
Intensive Care Unit.
- 5.56% of older adults died;
- Proportion of older adults with severe grade IV and V pneumonia 
index was higher than that of young and middle-aged patients (p 
<0.001).
- Proportion of impairment of multiple lung lobes was higher in the 
older adult group, compared to the young and middle-aged group 
(p <0.001).
- Proportion of lymphocytes in the older adult group was lower 
compared to the young and middle age group (p <0.001).
- The older adults, compared to the younger group, presented 
higher percentages of complications during hospitalization, 
being: severe acute respiratory syndrome (22.2%; 5.3%), acute 
cardiac injury (16.7%; 10.5%), acute liver and kidney injury (38, 9%; 
7.9%), secondary infection (22.2%; 13.2%) and shock (5.6%; 5.3%), 
respectively. However, the difference was not significant (p=0.337).




- 99 patients with 2019-nCoV pneumonia, 
37 older adults (≥ 60 years old).
-Period: January 1st to 20th (2020).
- 11.0% died, seven of whom were 60 years old and over.
- The first two deaths were male, had no chronic diseases and were 
61 (patient 1) and 69 years old (patient 2). Both patients had severe 
pneumonia and severe acute respiratory syndrome after hospitalization, 
being transferred to the Intensive Care Unit, where they received 
respiratory therapy assisted by an intubated ventilator. The intervals 
between the onset of symptoms and the use of ventilator-assisted 
breathing in the two patients were 3 and 10 days, respectively. The 
course of the disease and lung injuries progressed rapidly in both cases 
and both developed multiple organ failure in a short time.
To be continued
Chart 2 
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As for outcomes/complications resulting from COVID-19 
(n=8), there was a higher proportion of hospitalizations in older 
adults in Intensive Care Units(24), severe pneumonia(32) and a lower 
proportion of discharge in these units in relation to the younger 
groups(25). Descriptively, higher percentages of other complications 
resulting from the disease were identified in older adults, such as 
mortality(23,25,27,35), severe acute respiratory syndrome(26,37), cardiac 
injuries(32), hepatic injuries(26.32) and acute renal injuries(32), second-
ary infection(26,32), shock, acute respiratory distress syndrome(26), 
multiple organ failure(18), pneumonia(31), and use of mechanical 
ventilation(25-34) (Chart 3).
Those with advanced age had a higher severity of COV-
ID-19(5,23-24,27-28,30,32,.34) (n=8). Likewise, advanced age was related 
to the occurrence of death by COVID-19(17,23,25,27) (n=4). Also related 
to death: occurrence of acute respiratory distress syndrome and 
obstructive pulmonary disease, presence of comorbidities and 
symptoms of dyspnea(26), and greater development of serious 
charts(5,23,28,32) (Chart 3). 
Author, year, 
and country Type of study Study participants/Period Main results





- 630 adults with one or more 
comorbidities, being
153 older adults (≥ 65 years old).
-Period: March 13th to 20th (2020).
- The threat of a COVID-19 outbreak was rated as most serious by 
older adults aged 70 and over.
- Older adults showed less knowledge about the prevention 
and symptoms of COVID-19 compared to young people, but no 
significant difference was identified.





- 2,595 deaths associated with COVID-19.
-Period: from February 24th, 2020.
- Deaths by COVID-19 had a total discounted tax value (by 3%) 
of 924,346,795 international dollars in China. Being, 27.8% with 
people from 50 to 64 years old and 9.0% among those with 65 
years old and over.




-72 symptomatic patients with COVID-19, 
28 older adults (> 60 years old).
- Period: January 18th to February 3rd 
(2020).
- Patients were divided into two groups, being: young group (n=44; 
47.5 ± 8.7 years old) and older adult group (n=2; 68.4 ± 6.0 years old).
- The proportion of involvement of the pulmonary lobes was higher 
in the older adult group (71.4%) compared to the young group 
(36.4%) (p=0.009).
- The subpleural line (50.0%; p=0.030) and pleural thickening (71.4%; 
p=0.011) occurred in a greater proportion among older adults, 
compared to the young group (25.0%; 40, 9%, respectively).




- 4,880 nucleic acid (NAT) tests, with 1449 
older adults (≥ 60 years old).
- Period: January 22th to February 14th 
(2020).
- There was a higher proportion of positive NAT test rates as the 
age group increased, with 61.81% for cases> 70 years and 47.86% 
between 60 and 69 years old (χ2= 58.835; p <0.001).
- The positive test in fever clinics had a higher significant 
proportion among those older (p <0.001), being 57.33% and 
76.69% among those aged 60 to 69 years and> 70 years old, 
respectively.
- Binary logistic regression analysis showed that age was the risk 
factor for SARS-CoV infection (OR=1033; CI=1.029-1.037).





- 69 patients with confirmed SARS-CoV-2 
infection.
- Period: January 16th to 29th (2020).
- The cases were divided into two groups: adequate saturation 
(SpO2≥90%) and inadequate saturation (SpO2<90%).
- The mean age for the SpO2 ≥90% group was 37.0 years, while for 
SpO2 <90%, it was 70.5 years.
- All deaths occurred in the SpO2 <90% group formed by older 
patients, with more comorbidities and higher plasma levels of IL6, 
IL10, lactate dehydrogenase and C-reactive protein.
Chart 3 - Thematic categories of the main results on COVID-19 in older adults
 Thematic categories




Higher proportion of hospitalizations in Intensive Care Units(24) and severe pneumonia(32);
Lower proportion of discharge from Intensive Care Units(25);
High occurrence of composite endpoint (Intensive Care Unit and/or mechanical ventilation and/or death)(1);
High use of mechanical ventilation(25.32)
Higher mortality rate(23,25,27,33) 
Higher percentages of complications during hospitalization: severe acute respiratory syndrome(26,37); injuries 
- acute cardiac(32), hepatic(26.32) and acute renal(32); secondary infection(26.32); shock(32); acute respiratory distress 
syndrome(26); multiple organ failure(18) and pneumonia(31).




Variables related to death by 
COVID-19 
(n=8)
Acute respiratory distress syndrome and chronic obstructive pulmonary disease(26);
Advanced age(17-18, 23.25.27);
Presence of comorbidities and symptoms of dyspnea(26);
Greater development of serious charts(5,23,28,32) 
Chart 2 (concluded)
To be continued
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Also, the high cost resulting from deaths from the disease 
stands out(35); high prevalence of comorbidities among infected 
older adults, especially hypertension, diabetes mellitus and car-
diovascular diseases(26); higher occurrence of COVID-19 infection 
in older adults(37); treatment of COVID-19 with plasma infusion(10); 
andclinical analysis of COVID-19 in an immunocompromised pa-
tient(11)  andgenomic characteristics of the virus(19) (n=9) (Chart 3). 
With regard to studies that addressed the clinical signs of the 
disease in older adults (n=12), the results identified dyspnea(24,26-27), 
dry cough(17,20,26-27), fever(12.20,22-24,26-27), and fatigue(26), in addition 
to lower oxygen saturation rates(21,38). Symptoms of vdizziness, 
constipation(20), syncope(12), malnutrition(13) and rhabdomyolysis(14) 
(Chart 3) were also reported.
The diagnostic findings by computed tomography (n=8) 
identified changes in the lungs, in particular, the involvement of 
the pulmonary lobes(32,36). They also found a lower proportion of 
lymphocytes in older adults compared to young people(32) and 
the occurrence of lymphocytopenia(26) (Chart 3).
DISCUSSION
The current study is one of the first to map scientific knowledge 
about infection with the new coronavirus in older adults. Mapping 
the literature, which deals with aspects related to COVID-19 in this 
population, allowed to outline the different contexts of investiga-
tions with this theme, with regard to adverse outcomes/complica-
tions, the relationship of age and greater severity of the disease, 
deaths, clinical signs, diagnostic findings, and other information.
Most of studies in this review concentrated in China, because 
the outbreak started in this country(1), and presented a descriptive 
design, with non-probabilistic and consecutive samples. The op-
tion for the design, possibly, was due to the emergency nature of 
building knowledge about the COVID-19 pandemic. However, the 
set of findings shows that there are still few studies in the world, 
which were carried out specifically with older adults, highlighting 
the need to expand scientific knowledge on this topic. Thus, it is 
necessary to increasingly qualify scientific productions according 
to the evolution of the pandemic and, therefore, to advance in 
knowledge about the dynamics of the disease and its impact on 
society, on older adults, and their families. 
The greater likelihood that older adults will develop complications 
from infection with the new coronavirus compared to the general 
population was identified in this review. The analysis of information 
on adverse outcomes related to COVID-19 in older adults, such as 
progression of disease severity and hospital discharge, can provide 
information to guide the most effective treatment of the disease(39) 
in managing care and health service resources. 
It also favors organization of work in primary care, which, in 
addition to maintaining continuity of care for chronic diseases, 
should also undertake health surveillance actions. In this perspec-
tive, nurses, based on the situational health diagnosis, will be able 
to identify the most vulnerable older adults and promote health 
education. The approach to older adults’ social support network 
provides the capillarity of effective information on preventive mea-
sures and care related to COVID-19, postponing its adverse effects.
It is noteworthy that the mortality in the SARS-CoV-2 pandemic 
in older adults has also been observed in some studies(18,23,25,27,33), 
with advanced age related to this outcome(5,18,23-25,27-28,30,32,34). The 
highest proportion of severe pneumonia(31-32), associated with 
severe acute respiratory syndrome(26,37), acute cardiac(32), liver(26,32) 
and acute kidney(32) injuries, secondary infection(26,32), shock(32), 
acute respiratory distress syndrome(26), multiple organ failure(18) 
and use of mechanical ventilation(25-32) are the main outcomes 
related to the severity of the cases with worst prognosis. As a 
consequence, the use of mechanical ventilation(25,32) and hospi-
talization in Intensive Care Units(1,24) is high as well as the lower 
proportion of discharge in these hospital units. 
Likewise, acute respiratory distress syndrome and chronic 
obstructive pulmonary disease(26), old age(18,23,25,27), presence 
of comorbidities and dyspnea symptoms(27), and the greater 
 Thematic categories
(number of articles) Results of studies
Other information 
(n=9)
High costs related to deaths due to COVID-19(35) 
High prevalence of comorbidities in older adults and/or a higher proportion in relation to young people(24-25,27);
Common comorbidities: hypertension, diabetes mellitus and cardiovascular diseases(26);
Higher occurrence of infection by the new coronavirus in older adults(37);
Treatment of COVID-19 with plasma infusion(10);
Clinical evolution of COVID-19 in an immunodepressed patient(11);
Genomic characteristics(19).













Greater involvement of the pulmonary lobes in relation to young people(32,36);
Higher proportion of subpleural line and pleural thickening compared to young people(36); 
Lower proportion of lymphocytes(32);
Lymphocytopenia(26);
Higher number of lung injuries observed(29);
Greater bilateral pulmonary involvement and peripheral injuries(29);
Ground-glass opacities involving the pulmonary lobes(15-17,22). 
Chart 3 (concluded)
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development of serious charts(5,25,28,32) are responsible for the 
high death rate by COVID-19 in older adults. This relationship 
may be linked to physiological changes in the immune system 
resulting from the aging process as well as the greater number 
and complications of chronic diseases in older adults(4). The 
variables related to higher probability of death in older adults, 
verified in this review, contribute to outline the characteristics of 
older adults who are at higher risk for this outcome. 
Therefore, attention is needed to the particularities of the de-
velopment of the clinical picture in older adults. Dyspnea(24,26-27), 
fever(12,20,22-24,26-27), cough(19-20,26-27), fatigue(28), and lower oxygen 
saturation rates (<90%)(21,38) are the main clinical findings that 
can guide the diagnosis of COVID -19. In a cohort study, older 
adults with mild and/or moderate infection with the new coro-
navirus were found to have fever as the most frequent symptom 
(82-87%), followed by coughing (36-66%)(40). It should be noted 
that fever may not be present in older adults, referring to the 
need to investigate other symptoms, such as tiredness and 
cough(40). Additionally, most of these studies reported the signs 
and symptoms of COVID-19 in patients with infection diagnosed 
in hospitals(21,26,38,40), which assumes the relevance of advancing 
knowledge about the dynamics of the disease in older adults in 
representative population samples and before arriving at the 
hospital, seeking to prevent hospitalizations and worsening cases.
Considering the severity of the disease and its worst prognosis, 
the need to disseminate preventive measures for COVID-19 is 
reinforced in all areas of care, aiming at promoting older adults’ 
rights to life and health. In this regard, COVID-19 prevention 
among older adults with advanced age should be preferred, 
requiring interventions that can contain the worsening of the 
disease, in positive cases, minimizing the occurrence of these 
outcomes. Teams experienced in geriatrics and gerontology 
need to be agile in making the most appropriate decision in the 
context of older adults with advanced age.
Regarding diagnostic findings, computed tomography scans 
showed greater involvement of the pulmonary lobes(36-37) and 
proportion of subpleural line and pleural thickening(36); in rela-
tion to young people, lower proportion of lymphocytes(32) and 
lymphocytopenia(26). These radiological changes may be absent at 
the beginning of the disease and be minimal in the mild form(25). 
Therefore, other findings can be considered in the clinical assessment 
of older adults, such as the lowest proportion of lymphocytes(32) 
and lymphocytopenia(26), as verified in this scoping review.
Thus, clinical signs and imaging tests can guide the diagnosis 
of COVID-19 and provide early isolation and treatment for older 
adults. However, no studies were found that offered specific 
information about the treatment of this disease, showing the 
relevance of investments in research.
Considering the higher risk of complications and death by 
COVID-19 among older adults, its protection has been considered 
a priority action in Brazil(41). In this perspective, in addition to indi-
vidual clinical focus, it is necessary, in this phase of the pandemic, 
to advance in reflections and research on the broad geriatric and 
gerontological approach in caring for older adults, namely: what 
are the impacts of social isolation for older adults? How to deal with 
the various situations that disadvantage social mitigation measures 
in older adults, such as those who live in a context of high social 
vulnerability and live alone? What is the relationship between 
frailty and geriatric syndromes with the occurrence of COVID-19?
Such reflections and investigations are urgent, as they may sup-
port health professionals’ role in caring for older adults and their 
families before this pandemic context. Experts from the American So-
ciety of Geriatrics stressed the importance of expanding knowledge 
in gerontology and geriatrics to health professionals to understand 
the health peculiarities of older adults and their impact on coping 
with COVID-19(42). The Brazilian Society of Geriatrics and Gerontol-
ogy (SBGG - Sociedade Brasileira de Geriatria e Gerontologia), aware 
of the severity of the disease in older adults with comorbidities, 
recommends the adoption of measures to restrict social contact, 
avoiding crowds or trips during the COVID-19 pandemic. Moreover, 
it encourages that older adults should preferably be cared for at 
home, avoiding collective exposure in health services and that, in 
the event of being assisted by caregivers or health professionals, 
they should be screened for flu-like syndromes. Furthermore, spe-
cial attention should be given to older adults who live in nursing 
homes (NHs), as they tend to be more frail(43). 
In particular, nursing has a decisive role in facing the pandemic 
of COVID-19, considering that it corresponds to the largest health 
workforce and, in Brazil, they operate in all health care networks(44). 
Study limitations 
The types of studies available in scientific literature, at the be-
ginning of the pandemic, were mostly descriptive and few carried 
out experimental investigations, testing the main interventions. 
On the other hand, the studies included in this review were not 
analyzed for methodological limitations or risk of bias, as proposed 
for scoping review. These two aspects may have brought together 
investigations with a low level of evidence; however, they met 
the proposed objective of presenting an overview of scientific 
knowledge available worldwide about COVID-19 in older adults. 
Contributions to nursing
In this scoping review, no studies were identified that addressed 
nursing care directed to older adults affected with COVID-19. It 
is worth mentioning that the year 2020 was chosen to honor 
the bicentenary of Florence Nightingale, a precursor to modern 
nursing. Florence worked in the Crimean War(45) and, from her 
legacy, nurses have played an essential role in the prevention and 
control of infections, as well as in social mitigation measures(46). 
Such theoretical bases need to be rescued to support nursing 
professionals’ work in coping with COVID-19. The pandemic 
moment of COVID-19 reinforces the need for nurses to provide 
qualified and safe gerontological care, through fundamental 
professional training, and it is essential to develop care actions 
for older adults, considering, both in present and future scenarios, 
the particularities and specificities of this population.
CONCLUSION
Most of the research was carried out in China with a retro-
spective and case study type or case series design. With regard 
to case reports or case series, most aimed to report the clinical 
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characteristics, diagnostic findings and treatment perspectives of 
the first confirmed cases of the disease. As for the other studies, 
participants ranged from 17 to 13,909 older adults, with hetero-
geneous selection criteria. Six thematic categories were identified: 
adverse outcomes/complications resulting from COVID-19, age 
relationship and greater severity of COVID-19, variables related 
to death by COVID-19, clinical signs and symptoms, diagnostic 
findings, and other information. 
In general, scientific knowledge about COVID-19 in older adults 
is still incipient. However, they already indicate high vulnerability 
of older adults to the worsening of COVID-19 and to complications 
resulting from the disease, which includes a higher proportion of 
hospitalizations in Intensive Care Units and severe pneumonia and 
a lower proportion of hospital discharge compared to younger 
people. They also demonstrate that advanced age was related to 
the occurrence of death. There was also a major episode of CO-
VID-19 infection in older adults, high cost due to deaths from the 
disease and high occurrence of comorbidities in this population 
group, when infected. In this context, it is suggested to carry out 
national surveys with representative samples of older adults in 
different Brazilian states, in order to contribute to improving health 
care for older adults before the COVID-19 pandemic.
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